Melinda Gooderham, MSc, MD, FRCPC: Insights Into Lebrikizumab’s Sustained 3-Year Efficacy
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck Involvement
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
AbbVie Presents New Data on Efficacy of Upadacitinib in Moderate to Severe Atopic Dermatitis, High-Impact Areas
Spotlighting National Eczema Week 2024